RxDoctor Payments Data

John Massey, MD

Pain Medicine · Lincoln, NENPI 1922063528

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,215 of the $13,222 with a category attached, or 77.3%. 35 manufacturers reported payments, led by Boston Scientific at 33.9% of the total.

$13,222in general payments, 2019–2025

Across 380 payments — averaging $34.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$4K
  • Saluda Medical Americas, Inc.$3K
  • AbbVie$1K
  • Medtronic$1K
  • Si-bone, Inc.$958
  • Abbott$340
  • plus $2K from 29 others

What the payments were for

  • Travel & lodging$3,00723%
  • Food & beverage$10,21577%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,222 in reported general payments places this provider in the 85th percentile of 31 pain medicine providers in Nebraska.

See all pain medicine providers in Nebraska

Medicare billing

Part B allowed, 2024
$166,451
Medicare patients
387
Services billed
6,282

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl85$11,488
Buprenorphine33$5,030
Pregabalin111$4,413
Buprenorphine Hcl55$1,855
Gabapentin127$1,615
Duloxetine Hcl96$1,332
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen51$746
Tramadol Hcl56$417
Morphine Sulfate ErMorphine Sulfate12$388
Celecoxib12$239
Tizanidine Hcl22$215
Methadone Hcl14$182
Promethazine Hcl11$104
Topiramate12$86

Paid to pharmacies, not to this prescriber.

Other pain medicine in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →